David Launay

Latest

• Analysis of Unfolded Protein Response Activation in Colon Adenocarcinoma Epithelial Cells: A Proteomic Study
• Multi-view clustering of heterogeneous health data: Application to systemic sclerosis
• Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients
• Simple gene signature to assess murine fibroblast polarization
• Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?
• Interstitial pneumonia with autoimmune features: Evaluation of connective tissue disease incidence during follow-up
• Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis
• Effects of Immunoglobulins G From Systemic Sclerosis Patients in Normal Dermal Fibroblasts: A Multi-Omics Study
• Passages in culture and stimulation conditions influence protein expression of primary fibroblasts
• Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension
• Telomeropathies: A study of 15 cases
• Impact of disease on daily activities, emotions and quality of life of patients with hereditary angioedema
• Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertension
• F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study
• Serious Infectious Events and Immunoglobulin Replacement Therapy in Patients With Autoimmune Disease Receiving Rituximab: A Retrospective Cohort Study
• Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study
• Adherence to hydroxychloroquine in patients with systemic lupus: Contrasting results and weak correlation between assessment tools
• Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors
• Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doors
• Raising rare disease awareness using red flags, role play simulation and patient educators: results of a novel educational workshop on Raynaud phenomenon and systemic sclerosis.
• Low hormone levels during an attack of systemic capillary leak syndrome normalizing after treatment
• Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis
• Clinical Characteristics and Outcome of Patients with Infective Endocarditis Diagnosed in a Department of Internal Medicine
• Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
• Exploring illness perceptions of lupus patients for a motivational environment in therapeutic education
• Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross-Sectional Study
• Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis
• Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
• Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.
• Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry
• Factors associated with the 6-minute walk distance in patients with systemic sclerosis
• Pulmonary hypertension in systemic sclerosis: different phenotypes
• Pulmonary hypertension screening in systemic sclerosis: The best strategy remains to be defined
• Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity
• Role of B cells in the pathogenesis of systemic sclerosis
• B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis
• Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
• Special considerations in pregnant systemic sclerosis patients
• An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies
• B Cell Subsets Homeostasis and Functional Properties Are Altered in a Murine Model of Systemic Sclerosis
• Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysis
• Prognostic Factors of Functional Outcome in Systemic Sclerosis-Associated Interstitial Lung Disease
• Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity
• Effect of In Vitro and In Vivo Anakinra on Cytokines Production in Schnitzler Syndrome
• Relevance of Partitioning DLCO to Detect Pulmonary Hypertension in Systemic Sclerosis
• Survival and Prognostic Factors in Systemic Sclerosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis